Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) President Jon Christianson sold 522 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $128.04, for a total value of $66,836.88. Following the completion of the transaction, the president owned 65,919 shares of the company’s stock, valued at approximately $8,440,268.76. This represents a 0.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Jon Christianson also recently made the following trade(s):
- On Saturday, January 31st, Jon Christianson sold 515 shares of Palomar stock. The stock was sold at an average price of $121.75, for a total transaction of $62,701.25.
- On Saturday, January 31st, Jon Christianson sold 515 shares of Palomar stock. The shares were sold at an average price of $121.75, for a total transaction of $62,701.25.
- On Thursday, January 29th, Jon Christianson sold 1,158 shares of Palomar stock. The stock was sold at an average price of $122.04, for a total transaction of $141,322.32.
- On Thursday, January 29th, Jon Christianson sold 1,158 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total transaction of $141,322.32.
- On Wednesday, January 28th, Jon Christianson sold 1,991 shares of Palomar stock. The shares were sold at an average price of $119.88, for a total value of $238,681.08.
- On Tuesday, December 23rd, Jon Christianson sold 1,691 shares of Palomar stock. The stock was sold at an average price of $139.50, for a total value of $235,894.50.
Palomar Price Performance
NASDAQ PLMR traded down $2.81 during trading on Friday, reaching $120.61. The company’s stock had a trading volume of 332,759 shares, compared to its average volume of 323,567. The stock has a market capitalization of $3.20 billion, a PE ratio of 16.80 and a beta of 0.44. The firm has a fifty day moving average of $129.40 and a 200 day moving average of $123.10. Palomar Holdings, Inc. has a one year low of $107.75 and a one year high of $175.85.
Hedge Funds Weigh In On Palomar
Institutional investors and hedge funds have recently bought and sold shares of the stock. Summit Global Investments boosted its stake in shares of Palomar by 1.7% during the fourth quarter. Summit Global Investments now owns 4,646 shares of the company’s stock valued at $626,000 after purchasing an additional 79 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in Palomar by 3.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,546 shares of the company’s stock valued at $333,000 after buying an additional 82 shares during the last quarter. Quadrant Capital Group LLC boosted its position in Palomar by 2.0% during the 4th quarter. Quadrant Capital Group LLC now owns 4,464 shares of the company’s stock valued at $602,000 after buying an additional 88 shares during the period. Clearstead Advisors LLC grew its holdings in Palomar by 31.0% in the 3rd quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock worth $46,000 after acquiring an additional 94 shares during the last quarter. Finally, California State Teachers Retirement System grew its holdings in Palomar by 0.4% in the 2nd quarter. California State Teachers Retirement System now owns 24,207 shares of the company’s stock worth $3,734,000 after acquiring an additional 97 shares during the last quarter. 90.25% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of research analysts recently commented on the company. Keefe, Bruyette & Woods increased their target price on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research note on Tuesday, January 6th. Evercore initiated coverage on Palomar in a research report on Monday, February 9th. They set an “outperform” rating and a $150.00 price objective on the stock. JPMorgan Chase & Co. boosted their target price on Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 7th. Wall Street Zen raised Palomar from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Weiss Ratings raised shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Seven research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $162.17.
Check Out Our Latest Report on Palomar
More Palomar News
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Wall Street Zen upgraded PLMR to a “Buy”, adding to a string of favorable analyst notes and higher price targets from firms including Keefe, Bruyette & Woods, JPMorgan and Evercore — supporting upside vs. the consensus $162.17 target. Wall Street Zen Upgrade
- Positive Sentiment: Recent quarterly results (reported Feb. 11) showed a beat: $2.24 EPS vs. $2.06 expected and revenue of $492.6M (well above consensus), with 62.7% year-over-year revenue growth and healthy margins — fundamentals that support longer‑term earnings forecasts. Quarterly Results
- Neutral Sentiment: Institutional ownership is high (~90%); several funds adjusted positions in Q4. That concentration can reduce float and amplify moves but also means changes in institutional flows matter more than retail trading. Ownership Details
- Neutral Sentiment: Technical picture: the stock is trading below its 50-day SMA (~$129.40) and slightly below the 200-day SMA (~$123.10), signalling short-term weakness that may prompt additional selling until buyers reappear. Technicals
- Negative Sentiment: Insider selling: CFO T. Christopher Uchida sold 783 shares (about $100k) on Feb. 18, reducing his stake ~5%; President Jon Christianson and director Jonathan Knutzen also sold smaller tranches the same day. Multiple recent insider sales may be interpreted as near-term negative by market participants. Insider Selling
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
See Also
- Five stocks we like better than Palomar
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
